Mesoblast Ltd. (MESO)
13.38
+0.20
(+1.56%)
USD |
NASDAQ |
Oct 28, 16:00
14.40
+1.02
(+7.58%)
After-Hours: 20:00
Mesoblast Price : 13.38 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 12.95 | 13.20 | 12.88 | 13.18 | 215600.0 |
| Oct 26, 2026 | 12.38 | 12.48 | 12.33 | 12.39 | 107349.0 |
| Oct 23, 2026 | 12.38 | 12.38 | 12.21 | 12.28 | 102687.0 |
| Oct 22, 2026 | 12.80 | 12.93 | 12.49 | 12.55 | 236782.0 |
| Oct 21, 2026 | 12.98 | 13.12 | 12.78 | 12.83 | 555441.0 |
| Oct 20, 2026 | 11.95 | 12.51 | 11.95 | 12.41 | 245572.0 |
| Oct 19, 2026 | 12.48 | 12.50 | 11.89 | 11.95 | 617862.0 |
| Oct 16, 2026 | 13.91 | 13.91 | 12.94 | 13.28 | 615688.0 |
| Oct 15, 2026 | 13.56 | 14.00 | 13.50 | 13.95 | 290027.0 |
| Oct 14, 2026 | 13.75 | 13.95 | 13.68 | 13.79 | 225652.0 |
| Oct 13, 2026 | 14.26 | 14.26 | 13.90 | 13.90 | 260457.0 |
| Oct 12, 2026 | 14.47 | 14.47 | 14.27 | 14.27 | 143763.0 |
| Oct 09, 2026 | 13.93 | 14.38 | 13.93 | 14.29 | 178171.0 |
| Oct 08, 2026 | 13.62 | 13.76 | 13.41 | 13.75 | 239284.0 |
| Oct 07, 2026 | 13.71 | 14.10 | 13.71 | 13.94 | 242130.0 |
| Oct 06, 2026 | 13.90 | 13.90 | 13.58 | 13.61 | 404696.0 |
| Oct 05, 2026 | 14.09 | 14.30 | 13.97 | 14.22 | 181077.0 |
| Oct 02, 2026 | 14.34 | 14.34 | 14.01 | 14.08 | 265208.0 |
| Oct 01, 2026 | 14.44 | 14.49 | 14.19 | 14.32 | 332306.0 |
| Sep 30, 2026 | 14.82 | 14.89 | 14.65 | 14.65 | 199076.0 |
| Sep 29, 2026 | 14.60 | 14.93 | 14.60 | 14.87 | 158029.0 |
| Sep 28, 2026 | 14.48 | 14.62 | 14.31 | 14.50 | 243048.0 |
| Sep 25, 2026 | 15.30 | 15.35 | 15.10 | 15.12 | 126081.0 |
| Sep 24, 2026 | 15.15 | 15.59 | 15.15 | 15.48 | 236792.0 |
| Sep 23, 2026 | 15.75 | 15.75 | 15.20 | 15.29 | 451523.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Telix Pharmaceuticals Ltd. | 9.265 |
| Immutep Ltd. | 3.30 |
| CSL Ltd. | 34.64 |
| Ceryvyn Therapeutics Ltd. | 0.0231 |
| Propanc Biopharma, Inc. | 2.10 |
Price Related Metrics
| PS Ratio | 14.37 |
| Price to Book Value | 2.289 |
| Earnings Yield | -3.33% |
| Market Cap | 1.736B |